Definition
Edward Hawrot is an American pharmacologist and academic known for his research on G protein‑coupled receptors (GPCRs), particularly opioid receptors, and for his role as a faculty member at Stanford University.
Overview
Edward Hawrot serves as a Professor of Pharmacology in the Department of Pharmacology at the Stanford University School of Medicine. His research focuses on the molecular mechanisms of GPCR signaling, the development of peptide‑based therapeutics, and the structural biology of opioid receptors. He has authored numerous peer‑reviewed articles in journals such as Nature, Science, and Proceedings of the National Academy of Sciences, and he has been involved in collaborations that bridge basic pharmacology with drug discovery. Hawrot has also contributed to the mentorship of graduate students and postdoctoral fellows, and he has participated in various advisory panels related to pharmaceutical research and development.
Etymology / Origin
The given name “Edward” derives from the Old English Ēadweard, composed of the elements ēad (“wealth, fortune, prosperity”) and weard (“guardian, protector”). The surname “Hawrot” is of English origin; it likely originates from a locational or occupational name related to “haw” (a hedge or enclosure) and “rot” (a clearing or cultivated land), though specific genealogical details for the family name are not widely documented.
Characteristics
- Field of Expertise: Pharmacology, with a specialization in GPCR biology and opioid receptor pharmacodynamics.
- Academic Position: Professor, Department of Pharmacology, Stanford University School of Medicine.
- Research Contributions: Elucidation of peptide ligand interactions with GPCRs, development of novel analgesic compounds, and application of structural techniques (e.g., X‑ray crystallography, cryo‑EM) to study receptor conformations.
- Publications: Over 100 scholarly articles and several book chapters; notable works include studies on the κ‑opioid receptor and the design of biased agonists.
- Professional Service: Member of editorial boards for pharmacology journals; reviewer for NIH grant panels; participant in industry‑academic partnerships aimed at translating basic research into therapeutic candidates.
Related Topics
- G protein‑coupled receptors (GPCRs)
- Opioid receptor pharmacology
- Peptide therapeutics
- Stanford University School of Medicine
- Drug discovery and development
Note: The information presented reflects publicly available academic and professional records up to 2024 and does not include unverified personal details.